Oragenics Inc. short interest in 2021
In 2021, Oragenics Inc.'s disclosed short interest ran from 7.15% of shares outstanding on 15 Jan 2021 to 2.92% on 31 Dec 2021, a change of -4.23 percentage points. The year's high was 7.15% on 15 Jan 2021 and its low 1.84% on 31 Aug 2021, averaging 3.37% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.43 days on 30 Jun 2021. Full history: Oragenics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 7.15% (15 Jan 2021)
- End of year
- 2.92% (31 Dec 2021)
- Change
- -4.23 pp
- High
- 7.15% (15 Jan 2021)
- Low
- 1.84% (31 Aug 2021)
- Average
- 3.37%
- Highest days to cover
- 2.43 (30 Jun 2021)
- SEC filings marked
- 4
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 7.15% | 1.00 | |
| 29 Jan 2021 | 5.49% | 1.00 | |
| 12 Feb 2021 | 5.38% | 1.00 | |
| 26 Feb 2021 | 4.17% | 1.00 | |
| 15 Mar 2021 | 5.80% | 1.00 | 10-K filed |
| 31 Mar 2021 | 4.71% | 1.00 | |
| 15 Apr 2021 | 4.60% | 1.36 | |
| 30 Apr 2021 | 2.54% | 1.00 | |
| 14 May 2021 | 2.26% | 1.06 | 10-Q filed |
| 28 May 2021 | 2.24% | 1.00 | |
| 15 Jun 2021 | 2.48% | 1.03 | |
| 30 Jun 2021 | 2.35% | 2.43 | |
| 15 Jul 2021 | 2.36% | 2.21 | |
| 30 Jul 2021 | 4.99% | 1.00 | |
| 13 Aug 2021 | 3.14% | 1.16 | |
| 31 Aug 2021 | 1.84% | 1.02 | 10-Q filed |
| 15 Sep 2021 | 2.31% | 2.05 | |
| 30 Sep 2021 | 2.32% | 2.02 | |
| 15 Oct 2021 | 2.07% | 1.88 | |
| 29 Oct 2021 | 2.43% | 1.00 | |
| 15 Nov 2021 | 2.95% | 1.00 | 10-Q filed |
| 30 Nov 2021 | 2.54% | 1.30 | |
| 15 Dec 2021 | 1.90% | 1.18 | |
| 31 Dec 2021 | 2.92% | 1.00 |
See also: Oragenics Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.